+1 (619) 956-9114 info@myicfos.com
Follow us

Connect live...

Select the exhibitor's booth below and get connected live.

Click on "Edit" in the right panel to replace this with your own HTML code
About Vitranu

A drug delivery company developing a Tunable Extended-Release CapsuleTM (TERCTM) capable of long-term delivery of therapeutics via injection
Available from 1:30 PM - 4:00 PM (US/Pacific)
404 697 4853

Age-related macular degeneration and other retinal diseases cause debilitating loss of vision, and the standard of care treatment is an injection of therapeutics directly into the eye as often as every month. This injection frequency creates a huge burden on the healthcare system, and most importantly on patients and their caregivers. Vitranu is developing the Tunable Extended-Release Capsule or TERC, a sustained-release drug delivery technology designed to significantly reduce the frequency of eye injections, with the goal of six months or more of treatment in a single injection. By providing an extended duration of treatment, Vitranu aims to increase compliance and ultimately preserve the most precious gift of sight for more patients.